Sarasota Memorial Hospital
https://www.smh.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sarasota Memorial Hospital
ZymoGenetics Experiences a Biotech Disconnect
It's logical to think that synthetic thrombin is safer than bovine- or plasma-derived equivalents. But ZymoGenetics is finding out it's not an easy sell, especially to Wall Street.
ZymoGenetics' Biotech Disconnect
It's logical to think that synthetic thrombin is safer than bovine- or plasma-derived equivalents. But ZymoGenetics is finding out that it's not an easy sell, especially to Wall Street.
Nuts & Bolts Dealmaking
Deal-making between universities and medical device companies has historically been limited. Not only are such deals often too pricey for device companies, the nature of medical device innovation--more likely to be incremental improvements than quantum leaps forward--gives physicians and entrepreneurs an edge over universities. But that may be changing, as this look at university/medical device deals in the first half of 1997 shows.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice